Overview

Efficacy and Tolerability Study in Severe Chronic Obstructive Pulmonary Disease (COPD) Patients

Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
Efficacy and tolerability study in severe chronic obstructive pulmonary disease (COPD) patients.
Phase:
Phase 4
Details
Lead Sponsor:
AstraZeneca
Treatments:
Budesonide
Budesonide, Formoterol Fumarate Drug Combination
Formoterol Fumarate
Ipratropium
Theophylline